LCTX
#3337
Lineage Cell Therapeutics, Inc. Common Stock
1.2 2 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.69%
Monthly Change
-6.15%
6 month change
-28.95%
Year Change
-28.95%
Previous Close
1.2 8
Open
1.2 2
Low
1.2 1
High
1.2 3
Volume
450
Financials
- Market Capitalization 304.14 M
- Employee 77
- Founded 1990
- CEO N/A
- Website www.lineagecell.com
- Headquarter California, United States
- FIGI BBG000G8RJY6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.96
Price to sales ratio
26.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3319 |  EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -3.07% | -13.42% | +24.90% | +9.72% | 309.38 M USD | ||
| 3333 |  OABI OmniAb, Inc. - Common Stock | 2.11 USD | -7.86% | -12.45% | -8.66% | +1.93% | 305.89 M USD | ||
| 3340 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | +13.30% | 0.00% | +71.64% | +56.46% | 302.94 M USD | ||
| 3354 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.86 USD | +0.26% | -3.26% | +6.93% | -5.16% | 297.94 M USD |
Frequently asked questions about Lineage Cell Therapeutics, Inc. Common Stock
What is the Lineage Cell Therapeutics, Inc. Common Stock stock price today?
The current price of Lineage Cell Therapeutics, Inc. Common Stock (LCTX) is 1.22. Over the past 24 hours, the stock has changed by -4.69%. Follow the LCTX chart for real-time price dynamics.
What is the stock ticker of Lineage Cell Therapeutics, Inc. Common Stock?
Lineage Cell Therapeutics, Inc. Common Stock trades under the ticker LCTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lineage Cell Therapeutics, Inc. Common Stock stock going up?
LCTX has changed by -8.96% over the last week, -6.15% over the last month, and -28.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Lineage Cell Therapeutics, Inc. Common Stock net income for the last quarter?
Lineage Cell Therapeutics, Inc. Common Stock reported net income of -4.81 M for the last quarter. The previous quarter showed 851 K, which means net income changed by -665.45%.
How many employees does Lineage Cell Therapeutics, Inc. Common Stock have?
As of the latest available data, Lineage Cell Therapeutics, Inc. Common Stock has 77 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lineage Cell Therapeutics, Inc. Common Stock EBITDA?
Lineage Cell Therapeutics, Inc. Common Stock EBITDA is -7.58 M, and its EBITDA margin is -439.42%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lineage Cell Therapeutics, Inc. Common Stock stock?
You can buy Lineage Cell Therapeutics, Inc. Common Stock (LCTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lineage Cell Therapeutics, Inc. Common Stock stock?
Investing in Lineage Cell Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LCTX chart and related analysis on metatrader.com as part of your research.